These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. [The value of psychopharmacotherapy in the treatment of borderline personality disorder]. Leitner P; Serfling R Psychiatr Prax; 1993 Nov; 20(6):207-10. PubMed ID: 7906044 [TBL] [Abstract][Full Text] [Related]
29. Clinical trials of treatment for personality disorders. Paris J Psychiatr Clin North Am; 2008 Sep; 31(3):517-26, viii. PubMed ID: 18638650 [TBL] [Abstract][Full Text] [Related]
30. Rational polypharmacy in the bipolar affective disorders. Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735 [TBL] [Abstract][Full Text] [Related]
31. Pharmacotherapy of borderline states. Brinkley JR Psychiatr Clin North Am; 1993 Dec; 16(4):853-84. PubMed ID: 7906031 [TBL] [Abstract][Full Text] [Related]
32. Phenelzine, imipramine, and placebo in borderline patients meeting criteria for atypical depression. Parsons B; Quitkin FM; McGrath PJ; Stewart JW; Tricamo E; Ocepek-Welikson K; Harrison W; Rabkin JG; Wager SG; Nunes E Psychopharmacol Bull; 1989; 25(4):524-34. PubMed ID: 2698483 [TBL] [Abstract][Full Text] [Related]
33. [Review of psychopharmacological treatments in adolescents and adults with autistic disorders]. Baghdadli A; Gonnier V; Aussilloux C Encephale; 2002; 28(3 Pt 1):248-54. PubMed ID: 12091786 [TBL] [Abstract][Full Text] [Related]
34. The psychopharmacologic treatment of personality disorders. Klar H; Siever LJ Psychiatr Clin North Am; 1984 Dec; 7(4):791-801. PubMed ID: 6151648 [TBL] [Abstract][Full Text] [Related]
35. Psychopharmacology in child and adolescent psychiatry: a review of the past seven years. Part II. Campbell M; Cueva JE J Am Acad Child Adolesc Psychiatry; 1995 Oct; 34(10):1262-72. PubMed ID: 7592263 [TBL] [Abstract][Full Text] [Related]
36. [Personality disorder]. André C Rev Prat; 2008 Mar; 58(5):551-6; quiz 575. PubMed ID: 18524115 [No Abstract] [Full Text] [Related]
37. Pharmacotherapy of the borderline patient: a critical review and clinical guidelines. Kutcher SP; Blackwood DH Can J Psychiatry; 1989 May; 34(4):347-53. PubMed ID: 2567621 [TBL] [Abstract][Full Text] [Related]
38. Off-label use of atypical antipsychotics in personality disorders. Rosenbluth M; Sinyor M Expert Opin Pharmacother; 2012 Aug; 13(11):1575-85. PubMed ID: 21933032 [TBL] [Abstract][Full Text] [Related]
39. Pharmacotherapy for post-traumatic stress disorder. Sutherland SM; Davidson JR Psychiatr Clin North Am; 1994 Jun; 17(2):409-23. PubMed ID: 7937367 [TBL] [Abstract][Full Text] [Related]
40. Evidence for the treatment of borderline personality disorder. Gagliardi JP; Krishnan RR Psychopharmacol Bull; 2003; 37(1):30-46. PubMed ID: 14561947 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]